Archives: Speakers

Harris is Professor Of Manufacturing Systems in the Department of Engineering at King’s College London. He has a process engineering background with 20-years work experience in both industry and academia. In all his past and present roles, he is managing interdisciplinary projects that require integration and coordination. Harris is an expert in continuous RNA manufacturing. His work is focusing on addressing the challenges in the rapid design, development and scalable manufacture of RNA and other nucleic acids and has pioneered the application of flow technologies in RNA manufacture, of various types. His research has attracted over £25m and he is currently leading a unique multi-disciplinary, multi-million pound programme comprising both industry and academia, building the Biofoundry-in-a-Box (BiaB). The BiaB is a unique portable, multi purpose RNA microfactory designed for the rapid design and deployment of a range of therapeutics and vaccines, with Low and Middle Income Countries in mind. He has several patents in his name in the space of RNA manufacture and continuous bioprocessing and is highly experienced in technology transfer to industry through a variety of commercial routes.

David is the Sr. Director of Clinical Outsourcing and Contract Management at Cytokinetics.

He is responsible for developing transformational outsourcing solutions that fosters strong collaborative partnerships, mitigates operating risks and maximizes efficiencies via time and money. With over 22 years in the Pharma industry, David is an expert in clinical outsourcing strategy development through implementation, alliance management and clinical finance operations.

Dr. Patt is co-founder and principal of RadMD, and is an acknowledged expert in the field of applying medical imaging to new drug development.

He has numerous publications, has served on an NCI Advisory Panel, is a reviewer for major radiology journals, and has been an invited lecturer across the US and Europe on the use of medical imaging in clinical trials.

Dr Patt’s experience includes design and management of site and central reviews for over 500 oncology trials with a focus on early-phase efficiency for better decision-making.

An expert in corporate sustainability, Pippa is a key architect of corporate and national level Biodiversity frameworks and methodologies. She works across multiple sectors to develop strategic approaches to managing biodiversity, including the development of assessment and management frameworks that implement the mitigation hierarchy across mining portfolios.

Pippa led Fauna & Flora International’s Corporate Sustainability Programme and was the Senior Programme Manager at Cambridge University’s Institute for Sustainability Leadership.

She holds degrees in Environmental Science, Marine Biology, Zoology and International Development. She is a registered Professional Natural Scientist with over 25 years’ experience and specialises in the interface between business, NGOs, financing institutions and policy makers.

A freshwater ecology and nature-tech expert, Joe has 15+ years’ experience in ecology, including with many of the world’s largest mining companies. He has worked across multiple industries and continents to develop and deploy biodiversity monitoring solutions.

His PhD, quantifying ecological responses to habitat restoration, was hosted by London’s Natural History Museum and he has worked with the Earlham Institute to pioneer state-of-the-art biomonitoring approaches for assessing fish ecology.

He has spoken and contributed to a range of industry publications and events, including: Resourcing Tomorrow; the Inter-American Business and Nature Forum; Bloomberg; Copper, Gold, Silver (CGS) Columbia; International Mining; and, most recently a webinar hosted by Genomics British Columbia where he discussed new tools for biodiversity and nature reporting in the mining sector.

Kevin Brunn has over 13 years of experience in the maritime software industry. Kevin began their career in 2008 as Head of Clients and Markets, Maritime Software at GL Group. In 2014, Kevin joined DNV GL as Head of Business Development & Innovation, Ship Ecosystem, DNV GL – Digital Solutions. In this role, they drove business and market development activities, managed key accounts, and contributed to product development and product management activities. Kevin also took up product management responsibilities for the ShipManager Hull system. In 2022, Kevin became the Director of Business Development at ShipIn Systems.

Kevin Brunn holds an MBA in International Management from the University of Stralsund and a BSc in Environmental Science from Westminster College.

Anthea has over 30 years of experience within operational and recruitment leadership for clinical sites, technical validation, analytical and manufacturing aspects of cGMP, and quality oversight spanning GxPs.  She advocates for risk-based, phase-appropriate approaches designed to enable compliance, and has a drive for process and attention to detail with a focus on using technology to ease the quality burden.

Stephanie Hitchcock is a Director of Project Management at PCM Trials. Stephanie specializes in adapting trial designs for mobile visit services. She is passionate about expanding the use of high-quality, patient-centric models to drive clinical development. Stephanie is an expert in establishing logistics and procedures on a global scale for complex visit schedules and expanding the scope of what mobile visits can support globally.

Heidi Boehm, RN, BSN Senior Director, Program Delivery, MedTech – Based in the US, Heidi Boehm joined Premier Research in 2021 and currently functions as operational support for therapeutically aligned programs including client engagement and cross functional management. Prior to joining Premier Research, Heidi worked under two large CROs, where she gained extensive knowledge in global study delivery with an emphasis on medical device and diagnostics. Heidi offers more than 25 years of CRO, academic, site management, and nursing experience with extensive experience in cardiology, medical device, and diagnostics. Heidi is proficient in oncology, acute care, pulmonology, dermatology, women’s health, infectious disease, renal disorders, neuroscience, and surgical therapeutic areas. Heidi began her career as a registered nurse in 1998, working in acute care medical, oncology, and surgical units. Two years later, Heidi joined the cardiovascular acute and critical care unit. This experience led her to begin a new chapter in clinical research as a coordinator, working alongside physicians conducting research for eleven years. In 2013, Heidi joined the research team as project Manager at the University of Montana to study patient centered outcomes research in rural populations. Heidi then joined the CRO industry and has been actively working in a variety of roles with medium to large size CROs, gaining knowledge in diverse medical device and diagnostic fields of research.